These results imply that the innate immune resistance mediated by LMP1 oncogenic pathways and the adaptive immune resistance in response to inflammatory signals like IFN-γ are two distinct but synergistic mechanisms of PD-L1 regulation in EBV positive NPC. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.